Article
Sleep, sleep disorders and hypocretin (orexin).
Sleep medicine - 1 Jun 2004
Mignot Emmanuel
Abstract excerpt
Narcolepsy is a disabling neurologic condition affecting 1 in 2000 individuals, characterized by sleepiness, cataplexy, and transitions from wakefulness into rapid-eye-movement sleep. Current treatments include amphetamine-like stimulants and antidepressants. Human narcolepsy is HLA-associated, multigenic, and environmentally influenced. Positional cloning was used to isolate narcolepsy genes in canine families...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
